SCOPUS 정보 검색 플랫폼

Volumn 38, Issue 11, 1995, Pages 1589-1594

Campath‐1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis

(11) Weinblatt, Michael E a Maddison, Peter J a Bulpitt, Ken J b Hazleman, Brian L c Urowitz, Murray B d Sturrock, Roger D e Coblyn, Jonathan S f Maier, Agnes L f Spreen, William R g Manna, Vasant K g Johnston, Jeffrey M g

a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES (United Kingdom)

b UNIVERSITY OF CALIFORNIA (United States)

c ADDENBROOKE S HOSPITAL (United Kingdom)

d WELLESLEY HOSPITAL (Canada)

e GLASGOW ROYAL INFIRMARY (United Kingdom)

f BRIGHAM AND WOMEN S HOSPITAL (United States)

g Research Triangle Park ^* (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIRHEUMATIC AGENT; CORTICOSTEROID; METHOTREXATE; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; HYPOTENSION; IMMUNOTHERAPY; INTRAARTICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MULTICENTER STUDY; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VOMITING;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG TOLERANCE; HUMANS; INJECTIONS, INTRAVENOUS;

EID: 0028862268 PISSN: 00043591 EISSN: 15290131 Source Type: Journal
DOI: 10.1002/art.1780381110 Document Type: Article

Times cited : (117)

References (13)

1
- 0027503243
- Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritis
- (1993) Arthritis Rheum , vol.36 , pp. 307-318
- Moreland, LW¹ Bucy, RP² Tilden, A³ Pratt, PW⁴ Lo Buglio, AF⁵ Khazaeli, M⁶ Everson, MP⁷ Daddona, P⁸ Ghrayeb, J⁹ Kilgarriff, C¹⁰ Sanders, ME¹¹ Koopman, WJ¹²

2
- 0028238428
- Treatment of refractory rheumatoid arthritis with a chimeric anti‐CD4 monoclonal antibody: long‐term followup of CD4+ T cell counts
- (1994) Arthritis Rheum , vol.37 , pp. 834-838
- Moreland, LW¹ Pratt, PW² Bucy, RP³ Jackson, BS⁴ Feldman, JW⁵ Koopman, WJ⁶

3
- 0011978247
- Lack of clinical effect of CD4 monoclonal antibody therapy in early rheumatoid arthritis: a placebocontrolled trial (abstract)
- (1994) Arthritis Rheum , vol.37 , pp. S294
- Van der Lubbe, PA¹ Dijkmans, BAC² Markusse, HM³ Nassander, U⁴ Breedveld, FC⁵

4
- 0027299097
- Effects of administration of an anti‐CD5 plus immunoconjugate in rheumatoid arthritis: results of two phase II studies
- (1993) Arthritis Rheum , vol.36 , pp. 620-630
- Strand, V¹ Lipsky, PE² Cannon, GW³ Calabrese, LH⁴ Wiesenhutter, C⁵ Cohen, SB⁶ Olsen, NJ⁷ Lee, ML⁸ Lorenz, TJ⁹ Nelson, B¹⁰

5
- 4243823435
- Multicenter trial of an anti‐CD5 immunoconjugate in rheumatoid arthritis (abstract)
- (1994) Arthritis Rheum , vol.37 , pp. S295
- Olsen, NJ¹ Cush, JJ² Lipsky, PE³ Clair, EW⁴ Matteson, E⁵ Cannon, G⁶ McCune, WJ⁷ Strand, V⁸ Lorenz, T⁹

6
- 0026701264
- Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis
- (1992) J Rheumatol , vol.19 , pp. 1348-1352
- Kirkham, BW¹ Thien, F² Pelton, BK³ Pitzalis, C⁴ Amlot, P⁵ Denman, AM⁶ Panayi, GS⁷

7
- 0027156307
- Long term remission of intractable systemic vasculitis with monoclonal antibody therapy
- (1993) Lancet , vol.2 , pp. 1620-1622
- Lockwood, CM¹ Thiru, S² Isaacs, JD³ Hale, G⁴ Waldmann, H⁵

8
- 0026353531
- Humanized monoclonal antibody therapy treatment in rheumatoid arthritis
- (1991) J Rheumatol , vol.18 , pp. 1737-1738
- Kyle, V¹ Roddy, J² Hale, G³ Hazleman, BL⁴ Waldmann, H⁵

9
- 0026783632
- Humanised monoclonal antibody therapy for rheumatoid arthritis
- (1992) Lancet , vol.340 , pp. 748-752
- Isaacs, JD¹ Watts, RA² Hazleman, BL³ Hale, G⁴ Keogan, MT⁵ Cobbold, SP⁶ Waldmann, H⁷

10
- 0023945481
- The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
- (1988) Arthritis Rheum , vol.31 , pp. 315-324
- Arnett, FC¹ Edworthy, SM² Bloch, DA³ McShane, DJ⁴ Fries, JF⁵ Cooper, NS⁶ Healey, LA⁷ Kaplan, SR⁸ Liang, MH⁹ Luthra, HS¹⁰ Medgser, TA¹¹ Mitchell, DM¹² Neustadt, DH¹³ Pinals, RS¹⁴ Schaller, JG¹⁵ Sharp, JT¹⁶ Wilder, RL¹⁷ Hunder, GG¹⁸

11
- 0025266158
- Analysis of improvement in individual rheumatoid arthritis patients treated with disease‐modifying antirheumatic drugs, based on the findings in patients treated with placebo
- (1990) Arthritis Rheum , vol.33 , pp. 477-484
- Paulus, HE¹ Egger, MJ² Ward, JR³ Williams, HJ⁴

12
- 4243786317
- Continued lymphocyte suppression following single dose MAB therapy with Campath‐1H: a 20 month follow up (abstract)
- (1994) Arthritis Rheum , vol.37 , pp. S420
- Weinblatt, ME¹ Coblyn, J² Maier, A³ Anderson, R⁴ Helfgott, S⁵ Thurmond, L⁶ Spreen, W⁷ Johnston, J⁸

13
- 0028887830
- Synovial tissue response to treatment with Campath‐1H
- (1995) Arthritis Rheum , vol.38 , pp. 254-258
- Ruderman, EM¹ Weinblatt, ME² Thurmond, LM³ Pinkus, GS⁴ Gravallese, EM⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.